Refractory Lymphocytic Enterocolitis and Tumor Necrosis Factor Antagonist Therapy

Tumor necrosis factor-α antagonists such as infliximab or adalimumab may be a new treatment option for patients with severe refractory lymphocytic enterocolitis not responding to corticosteroids.